Literature DB >> 19034038

Effects of common antitussive drugs on the hERG potassium channel current.

Heike Deisemann1, Nadine Ahrens, Irene Schlobohm, Christian Kirchhoff, Rainer Netzer, Clemens Möller.   

Abstract

A common over-the-counter (OTC) non-opioid antitussive drug, clobutinol, was recently withdrawn from the market due to its potential to induce cardiac arrhythmias by a blockade of the potassium channel coded by the human ether-à-go-go-related gene (hERG). In this study, we investigated the effects of a number of antitussive compounds on the hERG ion channel current using patch-clamp electrophysiology, and compared the effects to that of clobutinol. The compounds clobutinol, pentoxyverine, dextromethorphan, and codeine inhibited the outward current in hERG transfected cells with half-maximal inhibition concentrations (IC50) of 1.9 microM, 3.0 microM, 5.1 microM, and 97 microM, respectively. For theobromine, no significant effect on the hERG current at a concentration up to 100 microM was detected. Safety margins between the effects of the drugs on the hERG ion channel current and their calculated maximal free therapeutic plasma concentration were calculated. These results were compared to assess potential risks of the compounds to induce torsade de pointes-type arrhythmias.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19034038     DOI: 10.1097/FJC.0b013e31818eec8d

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  4 in total

Review 1.  Opioids and Cardiac Arrhythmia: A Literature Review.

Authors:  Mina Behzadi; Siyavash Joukar; Ahmad Beik
Journal:  Med Princ Pract       Date:  2018-08-02       Impact factor: 1.927

2.  Automated electrophysiology makes the pace for cardiac ion channel safety screening.

Authors:  Clemens Möller; Harry Witchel
Journal:  Front Pharmacol       Date:  2011-11-23       Impact factor: 5.810

Review 3.  Natural products modulating the hERG channel: heartaches and hope.

Authors:  Jadel M Kratz; Ulrike Grienke; Olaf Scheel; Stefan A Mann; Judith M Rollinger
Journal:  Nat Prod Rep       Date:  2017-08-02       Impact factor: 13.423

4.  Sigma non-opioid receptor 1 is a potential therapeutic target for long QT syndrome.

Authors:  LouJin Song; Ramsey Bekdash; Kumi Morikawa; Jose R Quejada; Alison D Klein; Danielle Aina-Badejo; Kazushige Yoshida; Hannah E Yamamoto; Amy Chalan; Risako Yang; Achchhe Patel; Dario Sirabella; Teresa M Lee; Leroy C Joseph; Fuun Kawano; Junco S Warren; Rajesh K Soni; John P Morrow; Masayuki Yazawa
Journal:  Nat Cardiovasc Res       Date:  2022-02-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.